Alethea Capital Management’s Palisade Bio PALI Stock Holding History

Alethea Capital Management’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2	Closed	-$48K	–	101
2019 Q2	$48K	Hold	2	–	–	0.03%	80
2019 Q1	$73K	Hold	2	–	–	0.05%	74
2018 Q4	$51K	Hold	2	–	–	0.07%	57
2018 Q3	$176K	Hold	2	–	–	0.26%	69
2018 Q2	$182K	Hold	2	–	–	0.31%	58
2018 Q1	$271K	Hold	2	–	–	0.37%	73
2017 Q4	$283K	Hold	2	–	–	0.45%	64
2017 Q3	$217K	Hold	2	–	–	0.25%	68
2017 Q2	$952K	Hold	2	–	–	1.08%	29
2017 Q1	$868K	Buy	+2	New	+$763K	1.04%	31
2016 Q4	–	Sell	-2	Closed	-$684K	–	89
2016 Q3	$684K	Hold	2	–	–	0.95%	33
2016 Q2	$622K	Hold	2	–	–	0.85%	37
2016 Q1	$1.6M	Hold	2	–	–	1.78%	22
2015 Q4	$2.2M	Hold	2	–	–	2.55%	11
2015 Q3	$2.61M	Hold	2	–	–	3.96%	3
2015 Q2	$4.15M	Hold	2	–	–	6.37%	2
2015 Q1	$4.06M	Hold	2	–	–	4.48%	2
2014 Q4	$5.81M	Buy	+2	New	+$6.59M	5.92%	2

Other funds holding PALI

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

RCAG

Rehmann Capital Advisory Group Lansing, Michigan $2.18B AUM 23.73% 1-Year Est. Return

Alethea Capital Management's PALI Position: Q3 2019 in Review

Alethea Capital Management sold out of Palisade Bio (PALI) in Q3 2019, closing a stake of 2 shares — an estimated $48K sold.

Alethea Capital Management first reported a position in PALI in Q4 2014 and held it in 18 quarters. The position peaked at $5.81M in Q4 2014. 6 funds tracked by Wall St. Rank hold PALI as of Q3 2019.

Alethea Capital Management reported no remaining Palisade Bio position as of Q3 2019 after selling out during the quarter.
Alethea Capital Management sold 2 Palisade Bio shares in Q3 2019, an estimated $48K.
Alethea Capital Management first reported a position in Palisade Bio in Q4 2014 and held it in 18 quarters.
Alethea Capital Management's Palisade Bio position peaked at $5.81M in Q4 2014.
6 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2019.

Based on Alethea Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.